Medical writing support was provided by Diana Marouco, PhD, and Liam Gillies, PhD, of Apollo, OPEN Health Communications, and funded by Novo Nordisk A/S, in accordance with Good Publication Practice 3 (GPP3) guidelines (www.ismpp.org/gpp3)
Scenario 4: Switching vial concentrations mid-treatment Your pharmacy sends a 5mg/mL vial one month and a 2.5mg/mL vial the next
If youre struggling with weight management and are considering Ozempic semaglutide, its important to consult with a healthcare professional who prescribes Ozempic to determine if its the right fit for you
For example, atherosclerotic cardiovascular disease, which includes conditions such as stroke and heart attack, involves high levels of blood sugar
Novo Nordisk has filed at least 21 lawsuits nationwide against companies making purported copies of its drugs, said Brianna Kelley, a spokesperson for the company, and urges doctors to avoid them